A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis

Clin Lung Cancer. 2024 Jun;25(4):380-383. doi: 10.1016/j.cllc.2024.01.008. Epub 2024 Jan 30.
No abstract available

Keywords: Bypass track resistance; Cutaneous eruption; Lung adenocarcinoma; Oncogenic driver mutations; ROS1 tyrosine kinase inhibitor.

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / genetics
  • Carcinoma, Non-Small-Cell Lung* / pathology
  • Female
  • Humans
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / pathology
  • Male
  • Middle Aged
  • Mutation* / genetics
  • Protein-Tyrosine Kinases* / genetics
  • Proto-Oncogene Proteins B-raf* / genetics
  • Proto-Oncogene Proteins* / genetics
  • Skin Neoplasms* / genetics
  • Skin Neoplasms* / pathology

Substances

  • Proto-Oncogene Proteins B-raf
  • ROS1 protein, human
  • BRAF protein, human
  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases